By Lana Birbrair ( July 9, 2012, 4:50 PM EDT) -- Mylan Pharmaceuticals Inc. on Friday accused Warner Chilcott PLC and Mayne Pharma Group Ltd. of conspiring to prevent and delay generic competition to its anti-acne and bacterial infection drug Doryx by making minor changes to the drug every few years, with no real benefit....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.